Comparison of celite activated clotting time with kaolin activated clotting time during cardiac surgery.

Comparison of celite activated clotting time with kaolin activated clotting time during cardiac surgery. - ACT during cardiac surgery.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39708

Enrollment

125

Registered

2007-12-19

Start date

2008-03-28

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

activated clotting time anti-coagulation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients presenting for coronary artery bypass grafting and/or valve repair/replacement.

Exclusion criteria

Exclusion criteria: Patients with heredetary coagulopathies. Patients pre-operatively treated with unfractionated heparin.

Design outcomes

Primary

Measure	Time frame
the total amount of heparin given in each group.	—

Secondary

Measure	Time frame
fibrinopeptide A and postoperative blood loss	—

Countries

Netherlands

Outcome results